<img class="aligncenter wp-image-1506058 size-full" src="https://i1.wp.com/www.vanguardngr.com/wp-content/uploads/2020/12/Indonesia_china_covid_vaccine_dec_7_ePTgoOo.jpg?resize=600%2C450&#038;ssl=1" alt="EU body says approval of Covid vaccine going as quickly as possible" width="600" height="450" srcset="https://i1.wp.com/www.vanguardngr.com/wp-content/uploads/2020/12/Indonesia_china_covid_vaccine_dec_7_ePTgoOo.jpg?w=600&amp;ssl=1 600w, https://i1.wp.com/www.vanguardngr.com/wp-content/uploads/2020/12/Indonesia_china_covid_vaccine_dec_7_ePTgoOo.jpg?resize=300%2C225&amp;ssl=1 300w, https://i1.wp.com/www.vanguardngr.com/wp-content/uploads/2020/12/Indonesia_china_covid_vaccine_dec_7_ePTgoOo.jpg?resize=58%2C44&amp;ssl=1 58w, https://i1.wp.com/www.vanguardngr.com/wp-content/uploads/2020/12/Indonesia_china_covid_vaccine_dec_7_ePTgoOo.jpg?resize=260%2C194&amp;ssl=1 260w, https://i1.wp.com/www.vanguardngr.com/wp-content/uploads/2020/12/Indonesia_china_covid_vaccine_dec_7_ePTgoOo.jpg?resize=173%2C130&amp;ssl=1 173w" sizes="(max-width: 600px) 100vw, 600px" data-recalc-dims="1" /> The approval procedure for a coronavirus vaccine in the European Union cannot go any quicker than it is being conducted, but a decision should arrive before December 29, European Medicines Agency (EMA) director Emer Cooke said in Amsterdam on Monday. “We are working around the clock for the approval of the first Covid-19 vaccine,” she told reporters. However, she added that deadlines would be “constantly re-evaluated”. German Health Minister Jens Spahn has called for an acceleration of the process. The vaccine from Pfizer and BioNtech was first approved for use in Britain. The United States started its vaccination programme on Monday following emergency authorization. EMA head Cooke stressed that there would be no compromise on safety. Unlike the US and Britain, the EU does not grant emergency authorization for vaccines, meaning they must pass the usual tests. Vanguard News Nigeria US pharmaceutical firm Moderna reported early analysis on Monday that suggests its coronavirus vaccine is 94.5-per-cent effective, making it the second group to announce positive results from a large-scale clinical trial. The results are in the same league as those announced last week by drugmakers Pfizer and BioNTech, which say… November 17, 2020 In "News" With US pharmaceutical giant Pfizer and its German partner BioNTech applying for an emergency use authorization in the United States for their coronavirus vaccine and US biotech company Moderna expected to do so soon, here are the next steps in the approval and distribution process: - Evaluation begins right away… November 21, 2020 In "Coronavirus Updates" A vaccine jointly developed by Pfizer and BioNTech was 90 percent effective in preventing Covid-19 infections in ongoing Phase 3 trials, the companies announced Monday. The statement was released as soaring coronavirus cases across the world have forced many millions of people back into lockdown, causing further damage to ravaged… November 9, 2020 In "Health"